Natural killer cells and other innate lymphoid cells in cancer

L Chiossone, PY Dumas, M Vienne… - Nature Reviews …, 2018 - nature.com
Immuno-oncology is an emerging field that has revolutionized cancer treatment. Most
immunomodulatory strategies focus on enhancing T cell responses, but there has been a …

Regulation of ligands for the NKG2D activating receptor

DH Raulet, S Gasser, BG Gowen… - Annual review of …, 2013 - annualreviews.org
NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves
as a major recognition receptor for detection and elimination of transformed and infected …

Recognition of tumors by the innate immune system and natural killer cells

A Marcus, BG Gowen, TW Thompson, A Iannello… - Advances in …, 2014 - Elsevier
In recent years, roles of the immune system in immune surveillance of cancer have been
explored using a variety of approaches. The roles of the adaptive immune system have been …

Does the immune system naturally protect against cancer?

A Corthay - Frontiers in immunology, 2014 - frontiersin.org
The importance of the immune system in conferring protection against pathogens like
viruses, bacteria, and parasitic worms is well established. In contrast, there is a long-lasting …

Natural killer cells in myeloid malignancies: immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells

M Carlsten, M Järås - Frontiers in immunology, 2019 - frontiersin.org
Natural killer (NK) cells are large granular lymphocytes involved in our defense against
certain virus-infected and malignant cells. In contrast to T cells, NK cells elicit rapid anti …

Effect of NKG2D ligand expression on host immune responses

M Champsaur, LL Lanier - Immunological reviews, 2010 - Wiley Online Library
Natural killer group 2, member D (NKG2D) is an activating receptor present on the surface of
natural killer (NK) cells, some NKT cells, CD8+ cytotoxic T cells, γδ T cells, and under certain …

[HTML][HTML] Role of NKG2D and its ligands in cancer immunotherapy

H Liu, S Wang, J Xin, J Wang, C Yao… - American journal of …, 2019 - ncbi.nlm.nih.gov
The activating receptor natural killer group 2, member D (NKG2D) is involved in both innate
and adaptive immunities, and functions as a “master switch” in determining the activation …

NKG2D ligands as therapeutic targets

P Spear, MR Wu, ML Sentman, CL Sentman - Cancer immunity, 2013 - AACR
Abstract The Natural Killer Group 2D (NKG2D) receptor plays an important role in protecting
the host from infections and cancer. By recognizing ligands induced on infected or tumor …

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

A Hughes, J Clarson, C Tang, L Vidovic… - Blood, The Journal …, 2017 - ashpublications.org
Immunological control may contribute to achievement of deep molecular response in chronic
myeloid leukemia (CML) patients on tyrosine kinase inhibitor (TKI) therapy and may promote …

[HTML][HTML] Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells

D Nachmani, N Stern-Ginossar, R Sarid… - Cell host & …, 2009 - cell.com
Herpesviruses are known for their persistent lifelong latent infection, which is made possible
by their vast repertoire of immune-evasion strategies. We have previously shown that a …